Suggestions
Colin Keating
Leading health organisations in pursuit of effective & sustainable change through research and delivery of products. I will be relentless in striving for improved patient outcomes across various health disciplines.
Colin Keating is the Chief Executive Officer (CEO) of Microbio, an Australian biotechnology company focused on pathogen detection. He has over 25 years of experience across various industries, including health tech, financial services, and corporate travel, and has held leadership roles in both publicly listed and privately held companies. His expertise encompasses developing high-performing teams and executing strategic initiatives aimed at growth and customer engagement.13
Prior to joining Microbio, Keating served as the Interim CEO at MindBio Therapeutics, where he played a crucial role in building the business for sustainable growth following its listing on the Canadian Stock Exchange. His responsibilities included creating strategies for revenue generation and diversifying the company's investment approaches.12
Keating's appointment as CEO of Microbio was announced on October 24, 2023, effective from November 1, 2023. He expressed enthusiasm about joining Microbio and contributing to its mission.34 His extensive background also includes significant roles in major organizations such as American Express and Andersen Consulting, showcasing his ability to navigate diverse business environments effectively.2
